Researchers from the NCI report how 14-3-3 proteins keep the Parkinson’s-associated kinase LRRK2 inactive, offering structural insights into disease mechanisms and highlighting strategies to stabilize LRRK2 for potential therapeutic benefit.
- Juliana A. Martinez Fiesco
- Alexandra Beilina
- Ping Zhang